The influence of carvedilol on the production of reactive oxygen and nitrogen species by phagocytes

Biologia - Section Cellular and Molecular Biology

Volumn 60, Issue SUPPL. 17, 2005, Pages 125-128

  Gallová, Lucie ^a   Pavelková, Martina ^a   Mačičková, Tatiana ^b   Nosál', Radomír ^b   Číž, Milan ^a   Lojek, Antonín ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Carvedilol; Chemiluminescence; Macrophage; Nitric oxide synthase

Indexed keywords

MURINAE;

EID: 33751333418     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. ASBRINK, S., ZICKERT, A., BRATT, J., GYLLENHAMMAR, H. & PALMBLAD, J. 2000. No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions. Biochem. Pharmacol. 59: 1007-1013.
2. BREHM, B.R., BERTSCH, D., von FALLOIS, J. & WOLF, S.C. 2000. Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells. J. Cardiovasc. Pharmacol. 36: S401-S403.
3. CHENG, J., KAMIYA, K. & KODAMA, I. 2001. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential. Cardiovasc. Drug Rev. 19: 152-171.
4. DANDONA, P., KARNE, R., GHANÁM, H., HAMOUNA, W., ALMARA, A. & MAGSINO, C.J. 2000. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. Circulation 101:122-124.
5. GARAIOVÁ, I., MUCHOVÁ, J., ŠUSTROVÁ, M., BLAŽÍČEK, P., SIVOŇOVÁ, M., KVASNIČKA, P., PUESCHEL, S. & ĎURAČKOVÁ, Z. 2004. The relationship between antioxidant systems and some markers of oxidative stress in persons with Down syndrome. Biologia, Bratislava 59: 787-794.
6. GILLIAM, M.B., SHERMAN, M.P., GRISCAVAGE, J.M. & IGNARRO, L.J. 1993. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal. Biochem. 212: 359-365.
7. JANCINOVA, V., NOSAL, R. & DRABIKOVA, K. 2000. Inhibition of PMN leukocyte chemiluminescence by blood platelets - biological protection against destructive effects of reactive oxygen species? Biologia, Bratislava 55 (Suppl. 8): 67-71.
8. KUBALA, L., CIZ, M., VONDRACEK, J., CERNY, J., NEMEC, P., STUDENIK, P., CIZOVA, H. & LOJEK, A. 2002. Perioperative and postoperative course of cytokines and the metabolic activity of neutrophils in human cardiac operations and heart transplantation. J. Thorac. Cardiov. Surg. 124: 1122-1129.
9. LOJEK, A., KUBALA, L., CIZOVA, H. & CIZ, M. 2002. A comparison of whole blood neutrophil chemiluminescence measured with cuvette and microtitre plate luminometers. Luminescence 17:1-4.
10. NODA, T & AMANO, F. 1997. Differences in nitric oxide synthase activity in a macrophage-like cell line, RAW264.7 cells, treated with lipopolysaccharide (LPS) in the presence or absence of interferon-gamma (IFN-gamma): possible heterogeneity of iNOS activity. J. Biochem. 121: 38-46.
11. NOSÁL, R., JANČINOVÁ, V., ČÍŽ, M., DRÁBIKOVÁ, K., LOJEK, A. & FABRYOVÁ, V. 2005. Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells. Scand. J. Clin. Lab. Invest. 65: 55-64.
12. PAVELKOVA, M. & KUBALA, L. 2004. Luminol-, isoluminol- and lucigenin-enhanced chemiluminescence of rat blood phagocytes stimulated with different activators. Luminescence 19: 37-42.
13. PETRIKOVA, M., JANCINOVA, V., NOSAL, R., MAJEKOVA, M. & DANIHELOVA, E. 2002. Antiplatelet activity of carvedilol in comparison to propranolol. Platelets 13:479-485.
14. ROSS, D., VAN BRUGGEN, R. & MEISCHL, C. 2003. Oxidative killing of microbes by neutrophils. Microb. Infect. 5:1307-1315.
15. TADOLINI, B. & FRANCONI, F. 1998. Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism. Free Radic. Res. 29: 377-387.